Literature DB >> 15331167

Neuroprotective effect of L-carnitine in the 3-nitropropionic acid (3-NPA)-evoked neurotoxicity in rats.

Zbigniew Binienda1, Ashraf Virmani, Beata Przybyla-Zawislak, Larry Schmued.   

Abstract

A plant and fungal toxin, 3-NPA, acts as an inhibitor of mitochondrial function via irreversible inactivation of the mitochondrial inner membrane enzyme, succinate dehydrogenase (SDH). Inhibition of SDH disturbs electron transport and leads to cellular energy deficits and neuronal injury. We have shown that pretreatment with l-carnitine, while not significantly attenuating SDH inhibition, prevented hypothermia and oxidative stress-associated increased activity of free radical-scavenging enzymes. Here, a neurohistological method was applied to examine the effect of carnitine pretreatment against 3-NPA-induced neurotoxicity. Twenty adult male Sprague-Dawley rats were randomly divided into two groups (n = 10/group). Rats in the first group were injected twice with 3-NPA at 30 mg/kg s.c., 2 days apart, and the second group of animals received l-carnitine pretreatment at 100 mg/kg 30-40 min before 3-NPA administration. Rats in both groups were perfused 7 days later and their brains harvested. Degenerating neurons were identified and localized via the fluorescent marker Fluoro-Jade B. In the three animals that survived 3-NPA dosing, one exhibited no pathology, one exhibited moderate unilateral damage to the striatum, and the third exhibited extensive bilateral neuronal degeneration in multiple forebrain regions. In the seven surviving animals that received l-carnitine prior to 3-NPA insult, six exhibited no lesions, while one exhibited a modest unilateral lesion in the striatum. It appears that l-carnitine is protective against 3-NPA-induced toxicity, as reflected by both reduced mortality and significantly reduced neuronal degeneration.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331167     DOI: 10.1016/j.neulet.2004.05.031

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  Early nerve ending rescue from oxidative damage and energy failure by L: -carnitine as post-treatment in two neurotoxic models in rat: recovery of antioxidant and reductive capacities.

Authors:  Diana Elinos-Calderón; Yolanda Robledo-Arratia; Verónica Pérez-De La Cruz; José Pedraza-Chaverrí; Syed F Ali; Abel Santamaría
Journal:  Exp Brain Res       Date:  2009-06-30       Impact factor: 1.972

Review 2.  Mechanisms of ischemic neuroprotection by acetyl-L-carnitine.

Authors:  Santina A Zanelli; Nina J Solenski; Robert E Rosenthal; Gary Fiskum
Journal:  Ann N Y Acad Sci       Date:  2005-08       Impact factor: 5.691

3.  Cellular stress responses, mitostress and carnitine insufficiencies as critical determinants in aging and neurodegenerative disorders: role of hormesis and vitagenes.

Authors:  Vittorio Calabrese; Carolin Cornelius; Anna Maria Giuffrida Stella; Edward J Calabrese
Journal:  Neurochem Res       Date:  2010-11-13       Impact factor: 3.996

4.  Mice deficient in L-12/15 lipoxygenase show increased vulnerability to 3-nitropropionic acid neurotoxicity.

Authors:  Yan He; Rita C Akumuo; Yuan Yang; Sandra J Hewett
Journal:  Neurosci Lett       Date:  2017-02-14       Impact factor: 3.046

5.  Antioxidant strategy to rescue synaptosomes from oxidative damage and energy failure in neurotoxic models in rats: protective role of S-allylcysteine.

Authors:  Diana Elinos-Calderón; Yolanda Robledo-Arratia; Verónica Pérez-De La Cruz; Perla D Maldonado; Sonia Galván-Arzate; José Pedraza-Chaverrí; Abel Santamaría
Journal:  J Neural Transm (Vienna)       Date:  2009-10-29       Impact factor: 3.575

6.  Carnitine Serum Levels in Frail Older Subjects.

Authors:  Giulia Malaguarnera; Vito Emanuele Catania; Claudia Bonfiglio; Gaetano Bertino; Enzo Vicari; Michele Malaguarnera
Journal:  Nutrients       Date:  2020-12-19       Impact factor: 5.717

7.  Clinical Evidence of Acetyl-L-Carnitine Efficacy in the Treatment of Acute Ischemic Stroke: A Pilot Clinical Trial.

Authors:  Mehrdokht Mazdeh; Parnaz Abolfathi; Maryam Sabetghadam; Younes Mohammadi; Maryam Mehrpooya
Journal:  Oxid Med Cell Longev       Date:  2022-07-29       Impact factor: 7.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.